Jane Street’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Jane Street’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-80,700	Closed	-$2.22M	–	11209
2021 Q2	$2.22M	Sell	80,700 -53,300	-40%	-$1.05M	﹤0.01%	4132
2021 Q1	$2.21M	Buy	134,000 +44,000	+49%	+$1M	﹤0.01%	3830
2020 Q4	$1.66M	Buy	90,000 +74,100	+466%	+$1.33M	﹤0.01%	3829
2020 Q3	$216K	Buy	+15,900	New	+$245K	﹤0.01%	6337

Jane Street's TBIO Position: Q3 2021 in Review

Jane Street sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 94,733 shares — an estimated $2.61M sold.

Jane Street first reported a position in TBIO in Q3 2020 and held it in 4 quarters. The position peaked at $2.61M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Jane Street reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Jane Street sold 94,733 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $2.61M.
Jane Street first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
Jane Street's Translate Bio, Inc. Common Stock position peaked at $2.61M in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.